• Presented at European League Against Rheumatism (EULAR) Congress 2019

  • Authors: Gauchoux R, Boisbouvier A, Dos Santos R, Radoszycki L

Involving patients affected with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) in clinical trials may be highly challenging: in a worldwide context of competitive clinical research, patient engagement is key to optimize medical research and increase participation rates. The objectives of the study is to identify patients‘ motivations for and hindrances to joining a trial in order to increase participation rate by implementing tailored services and information.